Molecular Targeted Therapy
"Molecular Targeted Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Treatments with drugs which interact with or block synthesis of specific cellular components characteristic of the individual's disease in order to stop or interrupt the specific biochemical dysfunction involved in progression of the disease.
| Descriptor ID |
D058990
|
| MeSH Number(s) |
E02.319.574
|
| Concept/Terms |
Molecular Targeted Therapy- Molecular Targeted Therapy
- Molecular Targeted Therapies
- Targeted Therapies, Molecular
- Targeted Therapy, Molecular
- Therapies, Molecular Targeted
- Therapy, Molecular Targeted
- Targeted Molecular Therapy
- Molecular Therapies, Targeted
- Molecular Therapy, Targeted
- Targeted Molecular Therapies
- Therapies, Targeted Molecular
- Therapy, Targeted Molecular
|
Below are MeSH descriptors whose meaning is more general than "Molecular Targeted Therapy".
Below are MeSH descriptors whose meaning is more specific than "Molecular Targeted Therapy".
This graph shows the total number of publications written about "Molecular Targeted Therapy" by people in this website by year, and whether "Molecular Targeted Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 5 | 5 |
| 2011 | 7 | 13 | 20 |
| 2012 | 8 | 11 | 19 |
| 2013 | 3 | 16 | 19 |
| 2014 | 9 | 12 | 21 |
| 2015 | 6 | 11 | 17 |
| 2016 | 9 | 23 | 32 |
| 2017 | 11 | 12 | 23 |
| 2018 | 8 | 11 | 19 |
| 2019 | 8 | 19 | 27 |
| 2020 | 9 | 20 | 29 |
| 2021 | 6 | 11 | 17 |
| 2022 | 1 | 3 | 4 |
| 2023 | 1 | 0 | 1 |
| 2024 | 2 | 7 | 9 |
| 2025 | 1 | 7 | 8 |
| 2026 | 1 | 7 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Molecular Targeted Therapy" by people in Profiles.
-
Targeting synovial fibroblast KCa1.1 channels in rheumatoid arthritis. Curr Opin Immunol. 2026 Jun; 100:102747.
-
Advances and updates in pediatric anaplastic large cell lymphoma. Blood Adv. 2025 Oct 14; 9(19):4870-4880.
-
Radiomic analysis of patient and interorgan heterogeneity in response to immunotherapies and BRAF-targeted therapy in metastatic melanoma. J Immunother Cancer. 2025 Feb 12; 13(2).
-
Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling. Int J Cancer. 2024 11 15; 155(10):1792-1807.
-
Cardiac conduction diseases: understanding the molecular mechanisms to uncover targets for future treatments. Expert Opin Ther Targets. 2024 May; 28(5):385-400.
-
Targeting IL-1? as an immunopreventive and therapeutic modality for K-ras-mutant lung cancer. JCI Insight. 2022 06 08; 7(11).
-
Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial. J Clin Oncol. 2022 07 10; 40(20):2224-2234.
-
Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review. PLoS One. 2021; 16(4):e0250057.
-
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer. Cell. 2021 01 21; 184(2):384-403.e21.
-
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy. Cell. 2020 11 25; 183(5):1436-1456.e31.